XML 31 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jul. 03, 2006
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Acquired share capital of Bio-Maxtrix Scientific Gruop, Inc.     100.00%
Consideration of shares of common stock of the Company     10,000,000
Cancelation of shares of the Company owned and held by John Lauring     10,000,000
Percent of voting capital stock of the Company held by former stockholder of BMSG     80.00%
Owned subsidiary, Regen BioPharma, Inc. 12.20%    
Voting power of subsidiary, Regen Bio Pharma, Inc. 59.00%    
Shares of Entest BioMedical, Inc. for Securities Available for Sale 8,066,667    
Note receivable from Entest BioMedical $ 12,051    
Valuation allowance 100.00%    
Advertising expenses $ 0 $ 0